Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Prime-boost immunisation strategies for tuberculosis.

Helen McShane1, Adrian Hill

  • 1Centre for Clinical Vaccinology and Tropical Medicine, University of Oxford, Churchill Hospital, Oxford OX3 7LJ, UK. helen.mcshane@ndm.ox.ac.uk

Microbes and Infection
|May 14, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Baseline Treg frequency, Treg-associated immune checkpoint responses, and plasma IL-10 responses during controlled human malaria infection in semi-immune Kenyan adults: a secondary analysis of the CHMI-SIKA Study.

The Lancet. Microbe·2026
Same author

Lung mucosal and systemic responses at single-cell resolution in an aerosolized Mycobacterium bovis BCG human challenge model.

Cell reports. Medicine·2026
Same author

Domain arrangement-driven immunogenicity of a computationally designed mRNA vaccine targeting PPE68, IrtA, and PE9 of Mycobacterium tuberculosis.

Scientific reports·2026
Same author

Enhancing tuberculosis vaccine efficacy with a heterologous mRNA-ChAdOx1 prime-pull strategy targeting lung-resident memory T cells.

Frontiers in immunology·2026
Same author

The influence of murine cytomegalovirus infection on susceptibility to mycobacterial infection.

iScience·2026
Same author

Evolutionary age correlates with range size across plants and animals.

Nature communications·2025

Heterologous prime-boost vaccination strategies enhance cellular immunity against intracellular pathogens like Mycobacterium tuberculosis. Using BCG as a prime with recombinant poxviruses for boosting offers a practical approach to maintain BCG's benefits.

Area of Science:

  • Immunology
  • Vaccinology
  • Infectious Diseases

Background:

  • Effective vaccines against intracellular pathogens, such as Mycobacterium tuberculosis, require robust cellular immune responses.
  • Current vaccination strategies aim to optimize T cell activation, including CD4+ and CD8+ T cell populations.

Purpose of the Study:

  • To evaluate the efficacy of heterologous prime-boost immunization strategies for inducing cellular immunity against intracellular pathogens.
  • To explore the potential of using recombinant poxviruses as boosting vectors following BCG priming.

Main Methods:

  • The study focuses on comparing heterologous prime-boost immunization with homologous boosting strategies.
  • Recombinant poxviruses were investigated as boosting agents for T cell responses.
  • Bacillus Calmette-Guérin (BCG) was considered as a priming immunisation agent.

Related Experiment Videos

Main Results:

  • Heterologous prime-boost strategies were found to induce higher levels of both CD4+ and CD8+ T cells compared to homologous boosting.
  • Recombinant poxviruses demonstrated effectiveness in boosting pre-existing T cell responses.
  • Utilizing BCG as a priming immunisation in a heterologous prime-boost approach is a practical method.

Conclusions:

  • Heterologous prime-boost immunization, particularly using BCG followed by recombinant poxviruses, is a promising strategy for enhancing cellular immunity against Mycobacterium tuberculosis.
  • This approach offers a practical way to maintain the established benefits of BCG vaccination in pediatric populations.